Evaluation of Self‐Mediated Alternatives for Risk Testing Education and Return of Results ‐ eSMARTER: A randomized trial from the Alzheimer’s Prevention Initiative program
The eSMARTER study addresses the need for practical and scalable methods to responsibly communicate AD genetic and/or biomarker results. The eSMARTER digital platforms will be made available to support healthcare providers in returning AD genetic and/or biomarker results to individuals in clinical and research settings. All data and samples collected will be made available for public sharing.
Authors
- Emily A. Largent (ORCID: https://orcid.org/0000-0002-7536-5077)
- Kristin Harkins (ORCID: https://orcid.org/0000-0001-5360-1043)
- Carolyn Langlois
- Hayley Salata
- Joshua D. Grill (ORCID: https://orcid.org/0000-0002-4215-7589)
- Jessica B. Langbaum (ORCID: https://orcid.org/0000-0003-3848-1324)
- Trisha Walsh
- Brian L Egleston
- Elisabeth Wood
- Claire M Erickson
- J. Scott Roberts
- Nicholas J. Ashton
- Jason Karlawish
- Angela R. Bradbury
- Eric M. Reiman
Institutions
- Alzheimer's Association (US)
- Fox Chase Cancer Center (US)
- University of California, Irvine (US)
- University of Michigan (US)
- Banner Health (US)
- Banner Sun Health Research Institute (US)
- Banner Alzheimer’s Institute
- University of Pennsylvania (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_099986
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00